Category: Medicine

Autonomous mobile robot added to 21 hospitals in 2013

Last year, mobile robot maker Aethon says 21 hospitals started using Intralogistics, a supply chain logistics platform that uses the TUG autonomous robot to transport and deliver materials throughout hospitals. (Intralogistics also includes a software system that tracks medication deliveries to ensure chain-of-custody.) According to the company, more than 400 TUG robots now make 50,000

Mazor Robotics signs deal with group purchasing organization

Israel’s Mazor Robotics, creator of the Renaissance surgical guidance system, reported today that it has signed an agreement with one of the largest group purchasing organizations for hospitals and acute and non-acute healthcare facilities. Under the agreement, the company’s products will be available to the GPO’s members, which include hundreds of hospitals and freestanding surgery

Mazor will join two top indexes on the Tel Aviv Stock Exchange

Mazor Robotics reported today that, effective Dec. 15, it will be included in both the Tel Aviv Stock Exchange (TASE) Top 75 and Top 100 indexes. The Top 75 index, or TA-75, is a share index of the 75 most highly capitalized companies on the TASE not included in the TA-25 index. The TA-100 index, known as the Tel Aviv 100, is a stock

More robots mixing IV drugs: Health Robotics hits milestone

Health Robotics, whose machines automate the process of preparing IV drugs for hospitals and pharmacies, reported today that it has surpassed 500 worldwide installations under contract. The company set a record in its third quarter with 38 new sales, adding to significantly higher year-to-date sales overall. With 174 contracts thus far, compared to 79 new

Medical technology companies seek ideas to reduce infections

Hospital-acquired infections are both dangerous for patients and a burden for health care systems, but a new generation of robots offer hope for at least a partial solution. Recent studies have shown that products from companies including Xenex Disinfection Services can effectively reduce the spread of infection using ultraviolet light. Two medical technology companies are

MAKO Surgical agrees to be acquired for around $1.65B

Stryker Corporation, a medical technology company based in Michigan, yesterday reported a definitive agreement to acquire MAKO Surgical Corp. for a purchase price of about $1.65 billion. MAKO’s stock price exploded following the announcement, gaining more than 83 percent on the day to close at $29.45. MAKO builds robots designed to assist with orthopedic surgery.

Mazor Robotics fundraising to benefit U.S. sales, marketing

The Israeli business daily Globes reported yesterday that Mazor Robotics has filed a draft prospectus with the U.S. Securities and Exchange Commission to raise up to $46 million through the sale of American depositary shares on the Nasdaq stock market. American depositary shares make it easier for U.S. investors to invest in foreign companies; in this case, each

Vascular robotics maker wins MassTLC award for innovation

Corindus Vascular Robotics, which as its name implies develops precision vascular robotics, was awarded “2013 Innovative Technology of the Year for Robotics” last week at the 16th annual Massachusetts Technology Leadership Council awards gala. The annual technology awards are meant to highlight the strength of the Massachusetts tech ecosystem and were attended this year by

Surgical robots simultaneously break ground, endure scrutiny

Yesterday Mazor Robotics announced the world’s first (and second, and third) successful robot-aided deep brain stimulation (DBS) procedures. Using Mazor’s Renaissance robotic guidance system, neurosurgeon Nizam Razack performed the procedure at Celebration Health Hospital in Orlando, Fla. DBS, a recognized treatment for Parkinson’s Disease, involves surgically implanting a small battery-operated neurostimulator to deliver electrical stimulation

Mazor Robotics Q2 revenue doubles, beats estimates

Israeli surgical robotics firm Mazor Robotics yesterday reported promising financial results despite a net loss for second-quarter 2013, which ended June 30. According to CEO Ori Hadomi, “Our strong financial performance, highlighted by the revenue increase and gross margin expansion, demonstrates continued global adoption of our Renaissance systems as we ended the second quarter with 54